Trading Signals: REGN Stock Price Prediction and Forecast (Fri. Mar. 14, 2014 - Fri. Dec. 22, 2023)(Regeneron Pharmaceuticals Inc)
| REGN latest price $837.0700 (-0.06%) ($836.4100 - $853.9900) on Fri. Oct. 13, 2023. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 1.16% (three month average) | RSI | 50 | Latest Price | $837.0700(-0.06%) | Stocks Behave Similarly | Similar Stock List | Weekly Trend | REGN advances 0.3% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support REGN advance at 0% a week (0% probability) XLV(66%) IBB(60%) XLF(54%) DIA(53%) SPY(50%) | Factors Impacting REGN price | REGN will decline at least -0.58% in a week (0% probabilities). VXX(-45%) VIXM(-38%) USO(-21%) TBT(-21%) GLD(-17%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.58% (StdDev 1.16%) | Hourly BBV | 0.1 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $835.41(0.2%) | 10 Day Moving Average | $829.2(0.95%) | 20 Day Moving Average | $829.44(0.92%) | To recent high | -0.9% | To recent low | 16.6% | Market Cap | $88.753b | | | | Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. It product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, and Eric M. Shooter on January 8, 1988 and is headquartered in Tarrytown, NY. |